Oxana Beskrovnaya - Chief Scientific Officer, Dyne Therapeutics, Inc

As of March 14, 2022


Oxana Beskrovnaya Net Worth

  • Net worth is estimated to be at least $205.88K
  • Owns at least 53,676 units of Dyne Therapeutics, Inc stock
  • Sold an estimated value of $29K in the last 2 years at Dyne Therapeutics, Inc

Oxana Beskrovnaya Trading

  • Largest sale of shares was 1,444 units , worth over $22.95K on September 22, 2021
  • In total has made about 5 transactions over 2 years
  • Usually trades in September, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Oxana Beskrovnaya Mailing Address

  • Mailing address is C/o Dyne Therapeutics, Inc. 830 Winter Street Waltham MA 02451 MA

Dyne Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Joshua Brumm 2020 $482,667 - $3,134,366 $7,944,295 $299,877 $6,900 $11,868,105
Joshua Brumm 2019 $97,212 $180,000 - - - $102 $277,314
Romesh Subramanian, Ph.D. 2020 $371,875 - $987,285 $2,818,520 $186,395 $6,900 $4,370,975
Romesh Subramanian, Ph.D. 2019 $350,002 - - - $61,250 $408 $411,660
Susanna High 2020 $167,778 - $858,106 $2,646,267 $73,336 $418 $3,745,905
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm

Dyne Therapeutics, Inc Insider Trading

  • The most recent transaction was 308 units sold on March 14, 2022 by Richard Scalzo worth over $2.69K
  • In the last 15 years, insiders at Dyne Therapeutics, Inc sold an estimated value of $1.64B and bought an estimated value of $43.97M
  • The most active traders are Franklin Resources Inc,  Robert Flexon, President and CEO,  and Catherine James, EVP and General Counsel
  • Insider trading is most common in March, with the busiest year in 2015
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1